Israel -
Ibrani -
Ministry of Health
טייסברי
medison pharma ltd - natalizumab - תרכיז להכנת תמיסה לאינפוזיה - natalizumab 300 mg / 15 ml - natalizumab - natalizumab - tysabri is indicated as monotherapy for the treatment of patients with relapsing forms of multiple sclerosis . to delay the accumulation of physical disability and reduce the frequency of clinical exacerbations. the safety and efficacy of tysabri beyond two years are unknown. because tysabri increases the risk of progressive multifocal leukoencephalopathy (pml), an opportunistic viral infection of the brain that usually leads to death or severe disability. tysabri is generally recommended for patients who have had an inadequate response to, or are unable to tolerate, alternate multiple sclerosis therapies. safety and efficacy in patients with chronic progressive multiple sclerosis have not been studied.
Israel -
Ibrani -
Ministry of Health
דפאלפט סירופ
cts chemical industries ltd, israel - valproic acid as sodium - סירופ - valproic acid as sodium 40 mg/ml ml - valproic acid - valproic acid - generalized or partial epilepsy secondary generalized epilepsy and mixed forms of epilepsy.
Israel -
Ibrani -
Ministry of Health
jetpeel system
tavtech ltd - רופא - jetpeel multifunction skin rejuvenation system
Israel -
Ibrani -
Ministry of Health
dental products&materials(inc.disinfecta
"דנקר דנטל שיווק בע""מ." - רופא - "אביזרים , חומרים , מחטאים , מחטים להזרקה + נלווים לשימוש ברפואת שיניים"